I am a pediatric oncologist with expertise in cell therapy and hematopoietic stem cell transplantation (also known as bone marrow transplantation). As a physician-scientist, my main goal is to optimize the efficacy of stem cell transplantation and anticancer treatments while reducing their toxic side effects. In the laboratory, I am collaborating with immunologists, chemists, and engineers conducting studies designed to develop new strategies to improve immune function and antitumor activity in cancer patients and stem cell transplantation recipients. I hope that the results of my research will have direct impact on the development and design of new clinical trials, translating into benefits for hematopoietic stem cell transplantation recipients, as well as for patients suffering from cancer and immunodeficiencies.
- Clinical Expertise: Pediatric Hematology/Oncology; Cell Therapy
- Languages Spoken: English
- Education: MD, University of Erlangen, Nuremberg Medical School (Germany)
- Residencies: State University of New York (SUNY) Downstate Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more